logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

HR+ MBC: fulvestrant combination therapy beats fulvestrant monotherapy in Chinese meta-analysis

Patients had previously progressed on endocrine therapy.